Ernexa Therapeutics, Inc. (ERNA)
0.2657
0.00 (0.00%)
USD |
NASDAQ |
Mar 20, 16:00
0.2601
-0.01
(-2.11%)
After-Hours: 20:00
Ernexa Therapeutics EPS Diluted (Quarterly) : -0.1923 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -0.29 |
| Quince Therapeutics, Inc. | -0.2492 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| Tango Therapeutics, Inc. | -0.2945 |
| Aprea Therapeutics, Inc. | -0.3194 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.502M |
| Total Expenses (Quarterly) | 1.502M |
| Enterprise Value | 0.6937M |
| Earnings Yield | -415.6% |
| Normalized Earnings Yield | -387.81 |